INS and type 2 diabetes mellitus: When comparing our findings to a study investigating the relationship between insulin treatment and the risk of major adverse cardiovascular events (MACE) in stable type 2 diabetes patients, (Schwartz et al., 2016) especially those with recent acute coronary syndrome (ACS).